Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions

HE Davies; RS Sadler; S Bielsa; NA Maskell; NM Rahman; RJ Davies; BL Ferry; YC Lee

doi:10.1164/rccm.200811-1729OC

Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions

HE Davies, RS Sadler, S Bielsa, NA Maskell, NM Rahman, RJ Davies, BL Ferry, YC Lee

Research output: Contribution to journal › Article (Academic Journal) › peer-review

98 Citations (Scopus)

Abstract

Serum mesothelin is a new biomarker for the diagnosis of mesothelioma. Patients with mesothelioma commonly present with pleural effusions. To define the clinical utility of mesothelin quantification in pleural fluid, we assessed its additional value over pleural fluid cytology and its short-term reproducibility and reliability after pleural inflammatory processes, including pleurodesis.

Translated title of the contribution	Clinical Impact and Reliability of Pleural Fluid Mesothelin in Undiagnosed Pleural Effusions
Original language	English
Pages (from-to)	437 - 444
Number of pages	8
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	180
Issue number	5
DOIs	https://doi.org/10.1164/rccm.200811-1729OC
Publication status	Published - Sept 2009

Bibliographical note

Other identifier: PMID: 19299498

Research Groups and Themes

Academic Respiratory Unit

Access to Document

10.1164/rccm.200811-1729OC

Handle.net

Persistent link

Cite this

@article{66b1e0f32bcb435d92a2b99f7e8f6d51,

title = "Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions",

abstract = "Serum mesothelin is a new biomarker for the diagnosis of mesothelioma. Patients with mesothelioma commonly present with pleural effusions. To define the clinical utility of mesothelin quantification in pleural fluid, we assessed its additional value over pleural fluid cytology and its short-term reproducibility and reliability after pleural inflammatory processes, including pleurodesis.",

author = "HE Davies and RS Sadler and S Bielsa and NA Maskell and NM Rahman and RJ Davies and BL Ferry and YC Lee",

note = "Other identifier: PMID: 19299498",

year = "2009",

month = sep,

doi = "10.1164/rccm.200811-1729OC",

language = "English",

volume = "180",

pages = "437 -- 444",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1535-4970",

publisher = "American Thoracic Society",

number = "5",

}

TY - JOUR

T1 - Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions

AU - Davies, HE

AU - Sadler, RS

AU - Bielsa, S

AU - Maskell, NA

AU - Rahman, NM

AU - Davies, RJ

AU - Ferry, BL

AU - Lee, YC

N1 - Other identifier: PMID: 19299498

PY - 2009/9

Y1 - 2009/9

N2 - Serum mesothelin is a new biomarker for the diagnosis of mesothelioma. Patients with mesothelioma commonly present with pleural effusions. To define the clinical utility of mesothelin quantification in pleural fluid, we assessed its additional value over pleural fluid cytology and its short-term reproducibility and reliability after pleural inflammatory processes, including pleurodesis.

AB - Serum mesothelin is a new biomarker for the diagnosis of mesothelioma. Patients with mesothelioma commonly present with pleural effusions. To define the clinical utility of mesothelin quantification in pleural fluid, we assessed its additional value over pleural fluid cytology and its short-term reproducibility and reliability after pleural inflammatory processes, including pleurodesis.

U2 - 10.1164/rccm.200811-1729OC

DO - 10.1164/rccm.200811-1729OC

M3 - Article (Academic Journal)

C2 - 19299498

SN - 1535-4970

VL - 180

SP - 437

EP - 444

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

IS - 5

ER -

Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions

Abstract

Bibliographical note

Research Groups and Themes

Access to Document

Handle.net

Fingerprint

Cite this